Status:
ACTIVE_NOT_RECRUITING
Returning Research Results That Indicate Risk of Alzheimer Disease Dementia to Healthy Participants in Longitudinal Studies
Lead Sponsor:
Washington University School of Medicine
Conditions:
Alzheimer Disease
Dementia of Alzheimer Type
Eligibility:
All Genders
65+ years
Phase:
NA
Brief Summary
This is a study to evaluate the impact of returning research results that indicate a five-year risk estimate of Alzheimer disease dementia to participants without memory or thinking problems of the Kn...
Detailed Description
All participants without memory or thinking problems in a longitudinal observational cohort of aging (Memory and Aging Project) will be offered a five-year Alzheimer dementia risk estimate report that...
Eligibility Criteria
Inclusion
- Current Knight ADRC participants who had their clinical assessment in the previous year.
- Minimum age of 65 years old
- Participant must be classified as cognitively normal (CDR® = 0) at their last clinical assessment.
- Participant has either recent research brain MRI and amyloid PET scan results, or recent plasma amyloid measurements (ideally within the past two years, but up to five years will be acceptable due to COVID-19-related delays).
- Participant has genetic research results available including APOE status.
- Participant is currently consented to be contacted for other research opportunities through the Knight ADRC.
Exclusion
- There are no exclusion criteria, other than not meeting all of the inclusion criteria listed above.
Key Trial Info
Start Date :
February 19 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 31 2026
Estimated Enrollment :
450 Patients enrolled
Trial Details
Trial ID
NCT04699786
Start Date
February 19 2021
End Date
May 31 2026
Last Update
February 21 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Washington University School of Medicine
St Louis, Missouri, United States, 63110